Intermediate Risk Prostate Cancer

preview_player
Показать описание
MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for intermediate risk prostate cancer. Dr. Marshall is the chair of the radiation oncology department at the Medical University of South Carolina.

00:00 - What to expect with intermediate risk prostate cancer
00:45 What is intermediate risk prostate cancer?
01:01 the Gleason score
01:37 all options have high rate of cure
01:56 radical prostatectomy
03:28 external beam radiation
04:08 brachytherapy (seed implant)
09:02 erectile dysfunction after prostate cancer treatment
11:50 unfavorable intermediate risk
13:12 hormonal therapy
  1. MUSC Hollings Cancer Center
Рекомендации по теме
Intermediate-Risk Prostate Cancer 0:23:20

Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings

Choosing a Treatment 0:07:44

Choosing a Treatment for Intermediate Risk Prostate Cancer | Prostate Cancer Staging Guide

Intermediate Risk Prostate 0:18:58

Intermediate Risk Prostate Cancer

Active surveillance or 0:01:42

Active surveillance or intervention in intermediate-risk prostate cancer

Role of genomic 0:02:57

Role of genomic profiling in the management of intermediate-risk prostate cancer

Intermediate-Risk: Do You 0:14:06

Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI

Determining How Aggressively 0:05:54

Determining How Aggressively to Treat Relapsed & Intermediate-Risk Prostate Cancer | Mark Scholz...

Staging and Treatment 0:02:18

Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer

Intermediate Risk Prostate 0:02:00

Intermediate Risk Prostate Cancer: Felix Feng, MD

Intermediate Risk Prostate 0:01:37

Intermediate Risk Prostate Cancer: Omar Mian, MD, PhD

Point-Counterpoint: Active Surveillance 0:09:15

Point-Counterpoint: Active Surveillance for Intermediate-Risk Prostate Cancer - Pro

Low Risk (Gleason 0:06:42

Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13

Point-Counterpoint: Active Surveillance 0:09:59

Point-Counterpoint: Active Surveillance for Intermediate-Risk Prostate Cancer - Con

Intermediate Risk Prostate 0:02:41

Intermediate Risk Prostate Cancer: Daniel Spratt, MD

Active Surveillance in 0:11:13

Active Surveillance in Favorable Intermediate-Risk Prostate Cancer

Intermediate Risk Prostate 0:02:22

Intermediate Risk Prostate Cancer: Paul Nguyen, MD

SBRT for the 0:05:02

SBRT for the Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide

An Overview of 0:04:36

An Overview of Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask A Prostate Expert, Mark Scholz, M...

Proton Therapy Intermediate-Risk 0:06:46

Proton Therapy Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide

Radiation Therapy for 0:51:29

Radiation Therapy for Favorable Intermediate Risk Prostate Cancer w/ Dr. Amar Kishan | Ep. 53

Debate: Surgery vs. 0:09:44

Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery

MRI for Active 0:14:24

MRI for Active Survelliance in Intermediate Risk Prostate Cancer

Applying a Clinical 0:36:14

Applying a Clinical Genomic Nomogram for ADT Decisions in Intermediate Risk Prostate Cancer

”I have intermediate-risk 0:00:52

”I have intermediate-risk prostate cancer — how can RT + IRE improve my treatment?”